Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant RecipientsBrian J. Boyarsky, Jacqueline Garonzik‐Wang, William A. Werbel et al.|JAMA|2021Cited by 1k
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsBrian J. Boyarsky, Jacqueline Garonzik‐Wang, William A. Werbel et al.|JAMA|2021Cited by 536
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Sophie Alain, Barbara D. Alexander et al.|Clinical Infectious Diseases|2021Cited by 299
Early impact of COVID-19 on transplant center practices and policies in the United StatesBrian J. Boyarsky, Jacqueline Garonzik‐Wang, Teresa Po‐Yu Chiang et al.|American Journal of Transplantation|2020Cited by 244
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant RecipientsCaroline X. Qin, Dorry L. Segev, Nicole Ali et al.|Transplantation|2021Cited by 162